![Kenneth Huttner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Huttner
No open positions remaining
Profile
Kenneth Huttner worked as a Fellow at the National Institute of Child Health & Human Development from 1985 to 1988.
He then worked as a Medical Director at Interleukin Genetics, Inc. and as a Medical Director at CombinatoRx, Inc. from 2007 to 2009.
He worked as a Vice President-Clinical Development at Edimer Pharmaceuticals, Inc. from 2010 to 2015.
He also worked as an Executive Director-Translation Medicine at Novartis Institutes for Biomedical Research, Inc. from 2015 to 2017 and as a Vice President-Clinical Development at Bioverativ, Inc. from 2017 to 2019.
From 2019 to 2020, he worked as a Senior Vice President & Head-Clinical Development at LogicBio Therapeutics, Inc. Dr. Huttner earned a doctorate degree from Yale University.
Former positions of Kenneth Huttner
| Companies | Position | End |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-06-16 |
| BIOVERATIV INC | Chief Tech/Sci/R&D Officer | 2019-01-31 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 2017-06-30 |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Chief Tech/Sci/R&D Officer | 2015-02-27 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Chief Tech/Sci/R&D Officer | 2008-12-31 |
Training of Kenneth Huttner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
National Institute of Child Health & Human Development
 National Institute of Child Health & Human Development General GovernmentGovernment Conducts and supports basic and clinical research in maternal, child health and adults | Government |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
- Stock Market
- Insiders
- Kenneth Huttner
